Onconetix Inc.(ONCO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ONCO Onconetix Inc.

Not Yet Opened 04-16 16:00:00 EDT

0.7600

-0.0015

-0.20%

盘后0.7400

-0.0200-2.63%

19:59 EDT

High0.7800	Low0.6900	Vol2.01M
Open0.7100	D1 Closing0.7615	Amplitude11.82%
Mkt Cap527.97K	Tradable Cap190.93K	Total Shares694.70K
T/O1.47M	T/O Rate801.26%	Tradable Shares251.22K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ONCO","market":"US","secType":"STK","nameCN":"Onconetix Inc.","latestPrice":0.76,"timestamp":1776369600000,"preClose":0.7615,"halted":0,"volume":2012917,"hourTrading":{"tag":"盘后","latestPrice":0.74,"preClose":0.76,"latestTime":"19:59 EDT","volume":87589,"amount":65941.360806,"timestamp":1776383951979,"change":-0.02,"changeRate":-0.026316,"amplitude":0.071711},"delay":0,"changeRate":-0.0019697964543663113,"floatShares":251220,"shares":694700,"eps":-82.81488,"marketStatus":"Not Yet Opened","change":-0.0015,"latestTime":"04-16 16:00:00 EDT","open":0.71,"high":0.78,"low":0.69,"amount":1467784.0516442,"amplitude":0.118188,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-82.81488,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"listingDate":1645160400000,"exchange":"NASDAQ","adjPreClose":0.7615,"preHourTrading":{"tag":"盘前","latestPrice":0.7359,"preClose":0.7615,"latestTime":"09:28 EDT","volume":111457,"amount":82054.0192408,"timestamp":1776346083084,"change":-0.0256,"changeRate":-0.033618,"amplitude":0.116349},"postHourTrading":{"tag":"盘后","latestPrice":0.74,"preClose":0.76,"latestTime":"19:59 EDT","volume":87589,"amount":65941.360806,"timestamp":1776383951979,"change":-0.02,"changeRate":-0.026316,"amplitude":0.071711},"volumeRatio":0.037809},"requestUrl":"/m/hq/s/ONCO/wiki","defaultTab":"wiki","newsList":[{"id":"2628243675","title":"HRT Financial acquires $126,694 of Onconetix common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2628243675","media":"Reuters","labels":["insiderTrades"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2628243675?lang=en_us&edition=fundamental","pubTime":"2026-04-17 02:31","pubTimestamp":1776364270,"startTime":"0","endTime":"0","summary":"HRT Financial LP, 10% owner of Onconetix, reported open-market purchases of 166,904 Class A shares.Purchases were priced at USD 0.76 to USD 0.77 per share.Stake rose to 197,052 Class A shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDLn1Wzl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"HRT Financial acquires $126,694 of Onconetix common shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628624337","title":"Onconetix files Form 3 as HRT Financial LP reports beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2628624337","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628624337?lang=en_us&edition=fundamental","pubTime":"2026-04-17 02:23","pubTimestamp":1776363781,"startTime":"0","endTime":"0","summary":"HRT Financial filed a Form 3 initial beneficial ownership statement for Onconetix on April 16, 2026.HRT Financial disclosed direct ownership of 104,498 Onconetix Class A Shares.Reporting person checked status as a 10% owner.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL5rRmxR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626182688","title":"Onconetix says Realbotix acquisition expected to close in second half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626182688","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626182688?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:34","pubTimestamp":1775738047,"startTime":"0","endTime":"0","summary":"Onconetix signed a definitive share exchange agreement to acquire 100% of Realbotix LLC in an all-stock transaction.Closing is expected in second half of 2026, subject to Onconetix shareholder approval and other closing conditions.Combined company is expected to trade on Nasdaq following closing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL3hSzPS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4585","LU2210150020.SGD","LU2095319765.USD","IE00BN0W2V16.EUR","ONCO","IE00BN0W2T93.GBP","BK4588","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014005.SGD","IE00BN0W2W23.USD","NDAQ","BK4112","BK4139","IE00B3QW5Z07.USD","SG9999014021.USD","SG9999014039.USD","IE00BKPKM429.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624091685","title":"Onconetix says Realbotix expects delivery of 19 robots as acquisition pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2624091685","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624091685?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:33","pubTimestamp":1775133205,"startTime":"0","endTime":"0","summary":"Onconetix signed definitive share exchange agreement to acquire 100% of Realbotix LLC in an all-stock deal.Combined company expected to trade on Nasdaq following closing anticipated in second half of 2026.Realbotix expects delivery of 19 previously ordered AI humanoid robots across March, April, May 2026 as production scales.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL2hsxHm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014021.USD","IE00BKPKM429.USD","NDAQ","IE00B64PRP62.GBP","SG9999014039.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","LU2095319765.USD","LU2210149790.SGD","LU2210150020.SGD","ONCO","BK4585","BK4112","BK4139","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU0314104364.USD","BK4588","IE00BN0W2V16.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624509976","title":"Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2624509976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624509976?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:30","pubTimestamp":1775133001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUA4R7NB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624555900","title":"Onconetix names David White CEO as it pursues Realbotix acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2624555900","media":"Reuters","labels":["executive","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624555900?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:41","pubTimestamp":1774993284,"startTime":"0","endTime":"0","summary":"Onconetix named David White chief executive officer, effective March 18, 2026, as it works to complete planned acquisition of AI humanoid-robot developer Realbotix.White brings more than 30 years of executive leadership, including CEO roles at American Student Transportation Partners and TransCare.Sammy Dorf joined Onconetix board and audit committee, effective March 19, 2026.Dorf previously co-founded Verano Holdings, later founded Dreamlife Consulting, and is a partner at Blue Current.Outgoing interim CEO Karina Fedasz will remain interim chief financial officer.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLc90wrl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4588","SG9999014021.USD","NDAQ","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","BK4139","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","SG9999014005.SGD","ONCO","BK4112","BK4585","SG9999014013.SGD","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623812535","title":"BRIEF-Onconetix Appoints David White As Chief Executive Officer And Sammy Dorf As Member Of The Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2623812535","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623812535?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:45","pubTimestamp":1774961102,"startTime":"0","endTime":"0","summary":"BRIEF-Onconetix Appoints David White As Chief Executive Officer And Sammy Dorf As Member Of The Board Of DirectorsMarch 31 (Reuters) - Onconetix Inc ONCO.O:ONCONETIX APPOINTS DAVID WHITE AS CHIEF EXEC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA1B0G2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623818035","title":"Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2623818035","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623818035?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:30","pubTimestamp":1774960203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA1B0G2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623558181","title":"Onconetix Inc - Karina Fedasz to Continue as Interim CFO at Onconetix","url":"https://stock-news.laohu8.com/highlight/detail?id=2623558181","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623558181?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:30","pubTimestamp":1774960203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA1B0G2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623302388","title":"Oncopeptides Boosts Share Capital After Rights Issue to Support Cancer Drug Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2623302388","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623302388?lang=en_us&edition=fundamental","pubTime":"2026-03-31 17:00","pubTimestamp":1774947629,"startTime":"0","endTime":"0","summary":"An announcement from Oncopeptides AB ( ($SE:ONCO) ) is now available. Oncopeptides AB reported a change in its share and vote structure following t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncopeptides-boosts-share-capital-after-rights-issue-to-support-cancer-drug-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncopeptides-boosts-share-capital-after-rights-issue-to-support-cancer-drug-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","SG9999002414.USD","SG9999006266.SGD","LU0737861269.HKD","SG9999002406.SGD","IE0034224299.USD","LU0589944569.HKD","LU0823038988.USD","BK4548","LU0441851309.USD","LU0289960550.SGD","LU0261945553.USD","LU2008162690.USD","LU0348788117.USD","LU2238330802.EUR","SG9999005177.SGD","SG9999013486.USD","BK4220","LU0516422366.SGD","LU1839390173.USD","LU0516422952.EUR","LU0499858438.USD","LU0210637038.USD","LU2177674079.SGD","SG9999014492.USD","LU0251143029.SGD","BK4588","LU0516422440.USD","IE0001KFT4U8.USD","LU1770036033.HKD","LU2065171311.SGD","LU0072462343.USD","LU0345775950.USD","LU1048588211.SGD","LU1242518857.USD","LU0264606111.USD","SG9999002679.SGD","LU2125910500.SGD","LU0979878070.USD","BK4581","BK4085","LU0345776255.USD","LU0516423091.SGD","LU0048573645.USD","BK4585","LU0516423174.USD","LU0532188223.SGD","LU2065169927.USD","SG9999013460.SGD","LU1242518931.SGD","ONCO","LU2360107671.USD","IE0031814969.USD","LU0175139822.USD","LU0572939691.SGD","BK4535","BK4554","LU0572940350.SGD","LU2065171402.SGD","SG9999013478.USD","BK4503","LU0499858602.USD","LU1861220207.SGD","SG9999001135.SGD","LU1861217088.USD","LU2152927971.USD","SG9999002604.SGD","SG9999004360.SGD","LU0823039010.USD","LU2045819591.USD","LU2065170008.USD","LU2125910849.SGD","SGXZ58947870.SGD","BK4566","SG9999014484.SGD","IE00BD6J9T35.USD","LU2543165471.USD","SG9999002620.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622080885","title":"Onconetix files initial beneficial ownership statement; CEO David Allan White reports no securities beneficially owned","url":"https://stock-news.laohu8.com/highlight/detail?id=2622080885","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622080885?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:11","pubTimestamp":1774642277,"startTime":"0","endTime":"0","summary":"Onconetix said Chief Executive Officer David Allan White filed an initial Form 3 statement of beneficial ownership.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL2CV8Dt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622863808","title":"Onconetix files Form 3 initial beneficial ownership statement; director Sammy Dorf reports no securities beneficially owned","url":"https://stock-news.laohu8.com/highlight/detail?id=2622863808","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622863808?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:11","pubTimestamp":1774642268,"startTime":"0","endTime":"0","summary":"Sammy Dorf filed an initial Form 3 with the SEC reporting his position as a director of Onconetix.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL6QnwMz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622987584","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 11:16 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2622987584","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622987584?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:16","pubTimestamp":1774624568,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 11:16 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nAQN2LS3G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622821532","title":"Why Is Onconetix Stock (ONCO) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622821532","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622821532?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:33","pubTimestamp":1774614838,"startTime":"0","endTime":"0","summary":"Onconetix stock rallied on Friday after the company completed a reverse stock split.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-onconetix-stock-onco-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-onconetix-stock-onco-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622829689","title":"What's Going On With Onconetix Shares On Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622829689","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622829689?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:15","pubTimestamp":1774613700,"startTime":"0","endTime":"0","summary":"Onconetix, Inc.  shares are up during Friday’s premarket session.On Wednesday, the company disclosed a significant announcement regarding its acquisition of Realbotix.Onconetix has previously entered into a definitive agreement to acquire Realbotix for an undisclosed amount.The company expects the acquisition to enhance Onconetix’s capabilities in the rapidly evolving field of AI-driven technologies and robotics.The company recently showcased its humanoid robot in a live pre-standard 6G over-the-air trial at Ericsson’s U.S. headquarters.The demonstration highlighted Realbotix’s AI-agnostic architecture, allowing its humanoid robots to integrate seamlessly with various AI systems and cloud platforms.This flexibility positions Realbotix as a key player in the future of enterprise robotics. This will drive significant value for Onconetix as it moves forward with the acquisition.Additionally, this week, Onconetix announced a 1-for-5 reverse stock split, effective March 25.The stock is curr","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/27/Stock-Market-Growth-Vector-With-Green-Ca.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/27/Stock-Market-Growth-Vector-With-Green-Ca.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51505020/whats-going-on-with-onconetix-shares-on-friday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/03/51505020/whats-going-on-with-onconetix-shares-on-friday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["SMA","ONCO","BK4139","BK4217"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622847458","title":"Onconetix approves 1-for-5 reverse stock split; outstanding shares drop to about 0.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622847458","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622847458?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:03","pubTimestamp":1774605792,"startTime":"0","endTime":"0","summary":"Onconetix approved a 1-for-5 reverse stock split of its common stock, effective at 12:01 a.m. ET on March 25, 2026.Trading is expected to begin on a reverse split-adjusted basis at the market open on March 25, 2026, under the symbol ONCO.Fractional shares will be canceled and paid in cash based on the March 24, 2026 closing price.The action is expected to reduce shares outstanding from about 3.6 million to about 0.7 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the inform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL7Zf9zv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622002243","title":"Onconetix highlights Proclarix prostate cancer test; acquisition of Realbotix expected to close in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622002243","media":"Reuters","labels":["productRelease","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622002243?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:42","pubTimestamp":1774471365,"startTime":"0","endTime":"0","summary":"Onconetix reported that a Realbotix humanoid robot was used as a live connected endpoint in an Ericsson pre-standard 6G over-the-air trial, supporting real-time video transmission and interaction.The demonstration indicates potential enterprise demand for Realbotix systems in next-generation wireless environments, where low-latency connectivity can enable remote operation and real-time services.Realbotix’s AI-agnostic approach may broaden compatibility across multiple AI and cloud platforms, which could reduce customer lock-in concerns during procurement.Onconetix has a definitive all-stock agreement to acquire 100% of Realbotix, with closing anticipated in the second half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL88CkGj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622004959","title":"Onconetix files 8-K/A; White employment agreement appears as Exhibit 10.1 due to processing error","url":"https://stock-news.laohu8.com/highlight/detail?id=2622004959","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622004959?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:06","pubTimestamp":1774469165,"startTime":"0","endTime":"0","summary":"Onconetix filed an amended Form 8-K to correct a processing error that caused David White’s employment agreement to be omitted from an earlier Form 8-K.The company said the amendment files the employment agreement as Exhibit 10.1.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 25, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDLb0z8rr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622686003","title":"Onconetix highlights definitive share exchange to acquire Realbotix; closing expected in H2 FY2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622686003","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622686003?lang=en_us&edition=fundamental","pubTime":"2026-03-26 00:47","pubTimestamp":1774457234,"startTime":"0","endTime":"0","summary":"Onconetix has a definitive share exchange agreement to acquire 100% of Realbotix’s equity interests in an all-stock transaction.The deal is expected to close in the second half of 2026, subject to shareholder approval and required regulatory approvals.Following closing, the combined company is expected to trade on Nasdaq.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL16v9ZH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014021.USD","IE00BKPKM429.USD","NDAQ","IE00B64PRP62.GBP","SG9999014039.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","LU2095319765.USD","LU2210149790.SGD","LU2210150020.SGD","ONCO","BK4585","BK4112","BK4139","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU0314104364.USD","BK4588","IE00BN0W2V16.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622014670","title":"Onconetix Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2622014670","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622014670?lang=en_us&edition=fundamental","pubTime":"2026-03-25 07:50","pubTimestamp":1774396218,"startTime":"0","endTime":"0","summary":"19:50 EDT Onconetix (ONCO) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/onconetix-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/onconetix-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onconetix.com","stockEarnings":[{"period":"1week","weight":-0.377},{"period":"1month","weight":-0.7098},{"period":"3month","weight":-0.9065},{"period":"6month","weight":-0.955},{"period":"1year","weight":-0.97},{"period":"ytd","weight":-0.9026}],"compareEarnings":[{"period":"1week","weight":0.032},{"period":"1month","weight":0.046},{"period":"3month","weight":0.0145},{"period":"6month","weight":0.0561},{"period":"1year","weight":0.3348},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.03565},{"month":2,"riseRate":0,"avgChangeRate":-0.307056},{"month":3,"riseRate":0.2,"avgChangeRate":-0.25701},{"month":4,"riseRate":0,"avgChangeRate":-0.345765},{"month":5,"riseRate":0.75,"avgChangeRate":0.202404},{"month":6,"riseRate":0.25,"avgChangeRate":-0.145881},{"month":7,"riseRate":0.25,"avgChangeRate":0.061534},{"month":8,"riseRate":0,"avgChangeRate":-0.163365},{"month":9,"riseRate":0.25,"avgChangeRate":-0.19953},{"month":10,"riseRate":0.25,"avgChangeRate":-0.216685},{"month":11,"riseRate":0.25,"avgChangeRate":-0.325466},{"month":12,"riseRate":0,"avgChangeRate":-0.20858}],"exchange":"NASDAQ","name":"Onconetix Inc.","nameEN":"Onconetix Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Onconetix Inc.(ONCO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Onconetix Inc.(ONCO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Onconetix Inc.,ONCO,Onconetix Inc.股票,Onconetix Inc.股票老虎,Onconetix Inc.股票老虎国际,Onconetix Inc.行情,Onconetix Inc.股票行情,Onconetix Inc.股价,Onconetix Inc.股市,Onconetix Inc.股票价格,Onconetix Inc.股票交易,Onconetix Inc.股票购买,Onconetix Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Onconetix Inc.(ONCO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Onconetix Inc.(ONCO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction